ASA: No Drop in Recurrent Stroke Seen With Apixaban After Cryptogenic Stroke

FRIDAY, Feb. 16, 2024 -- For patients with recent cryptogenic stroke and evidence of atrial cardiopathy, the risk for recurrent stroke is not reduced with apixaban versus aspirin, according to a study published online Feb. 7 in the Journal of the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news